vTv Therapeutics Q2 EPS $（0.92）未达到$（0.82）估计值。

vTv Therapeutics (NASDAQ: VTVT) reported quarterly losses of $(0.92) per share which missed the analyst consensus estimate of $(0.82) by 11.52 percent. This is a 13.58 percent decrease over losses of $(0.81) per share from the same period last year.